This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: David Alan Griffin: Innovator in Antibiotic Development
Introduction
David Alan Griffin is a notable inventor based in Haselmere, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotic compounds. His work has the potential to impact the treatment of bacterial infections.
Latest Patents
David Alan Griffin holds 1 patent for his invention titled "Oxazolidinone derivatives with antibiotic activity." This patent includes compounds of the formula (I), or a pharmaceutically acceptable salt, or an in-vivo-hydrolysable ester thereof. This innovation represents a step forward in antibiotic research and development.
Career Highlights
Griffin is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca has allowed him to work on cutting-edge research and contribute to the advancement of medical science.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including Michael Barry Gravestock and Michael John Betts. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
David Alan Griffin's work in antibiotic development exemplifies the importance of innovation in healthcare. His contributions are paving the way for new treatments that could benefit countless patients worldwide.